Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

The neuroendocrine tumours pheochromocytomas and paragangliomas carry the highest
degree of heritability in human neoplasms, enabling genetic alterations to be traced to …

Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-
producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal …

Pheochromocytomas (PHEOs) are rare neuroendocrine tumors that arise from the
chromaffin cells of the adrenal glands. Paragangliomas (PGLs), the extra-adrenal …

Phaeochromocytomas and paragangliomas are relatively uncommon tumours which may be
manifest in many ways, specifically as sustained or paroxysmal hypertension, episodes of …

Pheochromocytomas and paragangliomas (PPGLs), rare chromaffin/neural crest cell tumors,
are commonly benign in their clinical presentation. However, there are a number of cases …

The ability of oestrogens and androgens to stimulate the growth of a number of endocrine
cancers is well established and several endocrine therapies are widely used to reduce the …

ABSTRACT Objective: Pheochromocytomas and paragangliomas (PPGLs) are
neuroendocrine tumors derived from adrenal or extra-adrenal locations, respectively. Upon …

Phaeochromocytomas (PCC) and paragangliomas (PGL) are rare tumours arising from the
chromaffin cells of the adrenal medulla (PCC) or the paraganglia located outside the …

The treatment of hormone hypersecretory syndromes caused by neuroendocrine tumors
(NETs) can be a major challenge. NETs originating from the small intestine often secrete …